Correction: Utility of Multi‑Analyte Protein Assay to Distinguish Multiple Sclerosis Clinical Relapse from Pseudoexacerbation.

Okuda DT, Moog TM, McCreary MC, Huddleston IJ, Wright CM, Burgess KW, Santoyo JR, Sguigna PV, Stüve O, Tran DH

Neurol Ther. 2026 Aug 14. PMID: 42601589. Abstract